Bio Preventive Medicine Corp.
6810
Rank in Stocks
#24563
Bio Preventive Medicine Corp., a biotechnology firm currently in the clinical... Bio Preventive Medicine Corp., a biotechnology firm currently in the clinical development phase, specializes in the proactive identification and mitigation of various illnesses. The company develops comprehensive strategies for the prevention, screening, and ongoing oversight of chronic conditions and cancer treatment. A key offering is the DNlite test, a suite of proprietary and medically validated non-intrusive urine analyses designed to aid in the management of diabetic kidney disease, encompassing specific products like DNlite-IVD103 and DNlite-DN_Score. Established in 2014, its main operations are located in Zhubei, Taiwan.
Share Price
$0.65084319
Last synced: 2026-11-10
Market Cap
$32.18M
Change (1 day)
2.64%
Change (1 year)
-18.11%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Bio Preventive Medicine Corp. (6810)
Category
Healthcare
EPS for Bio Preventive Medicine Corp. (6810)
EPS as of June 2026 TTM: $-0.06
According to Bio Preventive Medicine Corp.'s latest financial reports, its current EPS (TTM) is $-0.06. At the end of 2025 the company had an EPS of $-0.06, an increase over its 2024 EPS of $-0.08.
EPS history for Bio Preventive Medicine Corp. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.06 | 2.33% |
| 2025 | $-0.06 | -14.48% |
| 2024 | $-0.08 | 6.96% |
| 2023 | $-0.07 | -3.69% |
| 2022 | $-0.07 | -7.12% |
| 2021 | $-0.08 | 0.90% |
| 2020 | $-0.08 | 0.00% |
| 2019 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -25,604.89% |
US
|
|
| $-7.07 | 11,414.66% |
US
|
|
| $-5.29 | 8,515.64% |
AU
|
|
| $12.88 | -21,077.36% |
BE
|
|
| $21.56 | -35,214.01% |
NL
|
Questions about Bio Preventive Medicine Corp.'s earnings per share (EPS)
What is Bio Preventive Medicine Corp.'s earnings per share (EPS)?
Bio Preventive Medicine Corp.'s earnings per share (EPS) over the last twelve months is $-0.06, as of Jun 2026.
What was Bio Preventive Medicine Corp.'s earnings per share (EPS) in 2025?
In 2025, Bio Preventive Medicine Corp.'s earnings per share (EPS) was $-0.06, compared with $-0.08 in 2024.
How has Bio Preventive Medicine Corp.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Bio Preventive Medicine Corp.'s earnings per share (EPS) was highest in 2025 ($-0.06) and lowest in 2024 ($-0.08).
How does Bio Preventive Medicine Corp.'s earnings per share (EPS) compare with similar companies?
Bio Preventive Medicine Corp.'s earnings per share (EPS) ($-0.06) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.